Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26.5M
-
Number of holders
-
79
-
Total 13F shares, excl. options
-
7.68M
-
Shares change
-
+646K
-
Total reported value, excl. options
-
$40.7M
-
Value change
-
+$2.88M
-
Put/Call ratio
-
0.4
-
Number of buys
-
42
-
Number of sells
-
-35
-
Price
-
$5.29
Significant Holders of AVITA Medical, Inc. - Common Stock (RCEL) as of Q2 2025
96 filings reported holding RCEL - AVITA Medical, Inc. - Common Stock as of Q2 2025.
AVITA Medical, Inc. - Common Stock (RCEL) has 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.68M shares
of 26.5M outstanding shares and own 29.03% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (1.9M shares), VANGUARD GROUP INC (1.45M shares), GEODE CAPITAL MANAGEMENT, LLC (618K shares), STATE STREET CORP (529K shares), UBS Group AG (410K shares), Opaleye Management Inc. (390K shares), MILLENNIUM MANAGEMENT LLC (369K shares), NORTHERN TRUST CORP (260K shares), MORGAN STANLEY (222K shares), and JACOBS LEVY EQUITY MANAGEMENT, INC (138K shares).
This table shows the top 79 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.